论文信息 - Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices - 字舞流文

Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices

Define the prospective surveillance and reporting parameters for assessment of metallic stents used in clinical trials of superficial femoral artery atherosclerosis.

M. Dake | M. Jaff | G. Ansel | J. Pompa | Tony Yoder

[1] Jean-Paul Beregi,et al. Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery: Long-Term Results from the SIROCCO Trial , 2006, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[2] Johannes Lammer,et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. , 2006, The New England journal of medicine.

[3] M. Bates,et al. Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: A randomized trial , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4] Chris J. Hebert,et al. Nitinol Stent Fractures in the SFA The biomechanical forces exerted on the SFA provide a "stiff " challenge to endovascular stenting. , 2004 .

[5] Gerhard Ziemer,et al. Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery Disease: Six-Month Results , 2002, Circulation.